DK167984A - Alkaloidderivater - Google Patents

Alkaloidderivater Download PDF

Info

Publication number
DK167984A
DK167984A DK167984A DK167984A DK167984A DK 167984 A DK167984 A DK 167984A DK 167984 A DK167984 A DK 167984A DK 167984 A DK167984 A DK 167984A DK 167984 A DK167984 A DK 167984A
Authority
DK
Denmark
Prior art keywords
alkaloid derivatives
alkaloid
derivatives
Prior art date
Application number
DK167984A
Other languages
English (en)
Other versions
DK167984D0 (da
Inventor
George Joseph Cullinan
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DK167984D0 publication Critical patent/DK167984D0/da
Publication of DK167984A publication Critical patent/DK167984A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/816—Attached to the carrier via a bridging agent

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK167984A 1983-03-30 1984-03-26 Alkaloidderivater DK167984A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8308856 1983-03-30

Publications (2)

Publication Number Publication Date
DK167984D0 DK167984D0 (da) 1984-03-26
DK167984A true DK167984A (da) 1984-10-01

Family

ID=10540515

Family Applications (1)

Application Number Title Priority Date Filing Date
DK167984A DK167984A (da) 1983-03-30 1984-03-26 Alkaloidderivater

Country Status (24)

Country Link
US (1) US4596676A (da)
EP (1) EP0123441B1 (da)
JP (1) JPS59184189A (da)
KR (1) KR900001165B1 (da)
AR (1) AR241594A1 (da)
AT (1) ATE57187T1 (da)
AU (1) AU560423B2 (da)
BG (1) BG40813A3 (da)
CA (1) CA1225395A (da)
DE (1) DE3483336D1 (da)
DK (1) DK167984A (da)
EG (1) EG16223A (da)
ES (1) ES531080A0 (da)
FI (1) FI82939C (da)
GR (1) GR79898B (da)
HU (1) HU193283B (da)
IL (1) IL71365A (da)
NZ (1) NZ207674A (da)
PH (1) PH20036A (da)
PL (2) PL142818B1 (da)
PT (1) PT78321B (da)
RU (1) RU1774941C (da)
SU (2) SU1326196A3 (da)
ZA (1) ZA842348B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476659A (en) * 1982-11-09 1995-12-19 The Scripps Research Institute Cancerous B cell treatment using substituted nucleoside derivatives
DE3482444D1 (de) * 1983-03-30 1990-07-19 Lilly Industries Ltd Immunoglobulinkonjugate.
DE3484691D1 (de) * 1983-04-29 1991-07-18 Omnichem Sa Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4522750A (en) * 1984-02-21 1985-06-11 Eli Lilly And Company Cytotoxic compositions of transferrin coupled to vinca alkaloids
JPS62502684A (ja) * 1985-03-12 1987-10-15 ザ・ユニバ−シテイ・オブ・バ−モント・アンド・ステイト・アグリカルチユラル・カレツジ ビンブラスチン及びビンクリスチン型化合物の合成
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
EP0232693A3 (fr) * 1985-12-16 1988-04-06 La Region Wallonne Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
RU1787160C (ru) * 1986-12-24 1993-01-07 Эли Лилли Энд Компани Способ получени иммуноглобулинового конъюгата
CA1339775C (en) * 1988-06-10 1998-03-24 Shuzo Matsushita Antibody 0.5b to hiv-i gp 120 modified with toxic substance
US5095109A (en) * 1989-06-08 1992-03-10 University Of Vermont Novel alkaloids
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide
US5043336A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Cyclic imide derivatives of 4-desacetyl VLB c-3 carboxhydrazide
JP3100014B2 (ja) * 1991-12-10 2000-10-16 キヤノン株式会社 強誘電性液晶素子及び該素子の製造方法
AU5845594A (en) * 1992-11-13 1994-06-08 Scripps Research Institute, The Cancerous b cell treatment using substituted nucleoside derivatives
IL121789A (en) * 1996-10-03 2001-06-14 Rohm & Haas A medicinal product for inhibiting mammalian cell tumors
US20130178618A1 (en) 2012-01-10 2013-07-11 William Allen Boulanger Novel pharmaceutical intermediates and methods for preparing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3392173A (en) * 1964-03-09 1968-07-09 Lilly Co Eli Novel acyl derivatives of desacetyl-vincaleukoblastine and processes for their preparation
US3387001A (en) * 1964-10-19 1968-06-04 Lilly Co Eli Novel aminoacyl esters of desacetyl vincaleukoblastine
GB1541435A (en) * 1975-02-04 1979-02-28 Searle & Co Immunological materials
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
US4075214A (en) * 1976-05-17 1978-02-21 Eli Lilly And Company Preparation of leurosidine and novel leurosidine 4'-ethers and esters
US4087429A (en) * 1976-10-20 1978-05-02 Eli Lilly And Company 5' Acetoxy vinblastine 4' bis-sulfite
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4195022A (en) * 1978-03-27 1980-03-25 Eli Lilly And Company 4-Desacetoxy-4α-hydroxyvinblastine and related compounds
US4122082A (en) * 1977-11-07 1978-10-24 Eli Lilly And Company 4-Desacetoxy-4-oxovinblastine
US4166810A (en) * 1978-04-20 1979-09-04 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxyhydrazide
US4199504A (en) * 1978-05-15 1980-04-22 Eli Lilly And Company Bridged cathranthus alkaloid dimers
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
FI820020L (fi) * 1981-01-12 1982-07-13 Lilly Industries Ltd Immunoglobulinkonjugater
DE3484691D1 (de) * 1983-04-29 1991-07-18 Omnichem Sa Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4522750A (en) * 1984-02-21 1985-06-11 Eli Lilly And Company Cytotoxic compositions of transferrin coupled to vinca alkaloids

Also Published As

Publication number Publication date
ATE57187T1 (de) 1990-10-15
ES8506733A1 (es) 1985-07-16
PT78321A (en) 1984-04-01
AU560423B2 (en) 1987-04-09
RU1774941C (ru) 1992-11-07
IL71365A0 (en) 1984-06-29
FI841259A (fi) 1984-10-01
DK167984D0 (da) 1984-03-26
EG16223A (en) 1990-12-30
IL71365A (en) 1988-05-31
PL254899A1 (en) 1986-06-17
ZA842348B (en) 1985-06-26
BG40813A3 (en) 1987-02-16
JPS59184189A (ja) 1984-10-19
HU193283B (en) 1987-09-28
PL142754B1 (en) 1987-11-30
AR241594A1 (es) 1992-09-30
FI82939B (fi) 1991-01-31
GR79898B (da) 1984-10-31
FI841259A0 (fi) 1984-03-29
US4596676A (en) 1986-06-24
EP0123441B1 (en) 1990-10-03
PH20036A (en) 1986-09-04
ES531080A0 (es) 1985-07-16
NZ207674A (en) 1987-11-27
EP0123441A1 (en) 1984-10-31
PL142818B1 (en) 1987-12-31
SU1326196A3 (ru) 1987-07-23
CA1225395A (en) 1987-08-11
KR840008161A (ko) 1984-12-13
PT78321B (en) 1986-08-08
DE3483336D1 (de) 1990-11-08
SU1491341A3 (ru) 1989-06-30
KR900001165B1 (ko) 1990-02-27
FI82939C (fi) 1991-05-10
PL246932A1 (en) 1985-12-03
AU2614484A (en) 1984-10-04

Similar Documents

Publication Publication Date Title
DK158092D0 (da) Phenthanolaminderivater
DK159384D0 (da) Ergocalciferolderivater
DK35384A (da) Vinylcephalosporin-derivater
DK221384A (da) Isoindolderivater
DK20884D0 (da) Phenothiazonderivater
DK167984A (da) Alkaloidderivater
DE3471299D1 (de) Oxamic-acid derivatives
DK306284D0 (da) Substituerede phenylsulfonylguanidin-derivater
DE3464610D1 (de) 2-alkylthiopenem derivatives
DK354684D0 (da) Azol-dioxolan-derivater
DK522984D0 (da) Pyrazolopyridincykloalkanon-derivater
DK346984A (da) Formamidoximderivater
DE3477197D1 (de) 2-azacycloalkylthiopenem derivatives
DK261284A (da) Dihydropyridinderivater
DE3476803D1 (de) Furane-3-carboxylic-acid derivatives
DE3472258D1 (de) Thiodeazapurine derivatives
DE3474664D1 (de) Imidazoquinoline derivatives
DK470684A (da) Carbapenemderivater
DK536184A (da) Pyrimidoisoquinolinderivater
DK616784A (da) Pyrazolopyridinderivater
DE3464902D1 (de) 2-bromo-1-tetralone derivatives
DE3473268D1 (de) 5-fluorouracilnitroxylderivatives
BR8307679A (pt) Derivados de pirano
LV5762A4 (lv) Naftohinona atvasinajumi
DK154284A (da) Pyridylaminoethen-derivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)
PBP Patent lapsed